Advaxis
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, Advaxis sits in the top decile of US sponsors by registered trial count (#1,458 of 15,751 sponsors by registered trial count).
Advaxis: 9 sponsored US clinical trials, none currently recruiting.
Advaxis sponsors 9 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. 1 of these trials are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 1 trials.
Top-decile sponsor footprint
Advaxis ranks in the top decile of sponsors by registered trial count (#1,458 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Indexed trials (enrollment closed)
9 total, page 1 of 1
Study of ADXS-503 With or Without Pembro in Subjects With Metastatic Non-Small Cell Lung Cancer
NCT03847519
A Study of ADXS-NEO Expressing Personalized Tumor Antigens
NCT03265080
A Phase 2 Study of Axalimogene Filolisbac (ADXS11-001) in Participants With Carcinoma of the Anorectal Canal
NCT02399813
Study of ADXS11-001 in Participants With High Risk Locally Advanced Cervical Cancer
NCT02853604
Dose Escalation Study of ADXS31-164 in Subjects With HER2 Expressing Solid Tumors
NCT02386501
ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC)
NCT02325557
A Study of ADXS11-001 or MEDI4736 Alone or Combination In Cervical or Human Papillomavirus (HPV)+ Head & Neck Cancer
NCT02291055
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
NCT02164461
An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+
NCT01116245
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 2 |
| Phase 3 | 1 |
Therapeutic Areas
How the Advaxis early-phase archive is shaped
9 indexed studies, none listed as recruiting (0% open); 5 completed (56%).
Phase mix: 1 late (III/IV) vs 8 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.